Kuehn Law, PLLC is investigating whether certain officers and directors of CG Oncology, Inc. breached their fiduciary duties through potential self-dealing. This legal probe could lead to damages and changes in corporate governance to protect shareholders. Long-term CG Oncology investors are encouraged to contact the law firm as there may be a limited window to act. The investigation underscores the importance of shareholder rights and corporate accountability.
Bernstein upgraded Analog Devices (ADI) from Market Perform to Outperform following the company's record Q3 revenue of $4.02 billion, a 39.2% increase year-over-year and the first quarter surpassing $4 billion. The growth is fueled by strong demand i...
Beam Global reported better-than-expected earnings per share of -$0.14 and quarterly revenue of $8.56 million, a 174% increase from Q1 2026. The company improved its financial health with a 17.8% gross margin, reduced operating expenses, no debt, and...
Sociedad Química y Minera de Chile (SQM) reported a 646% increase in Q2 net income to $660 million, driven by record lithium sales of over 84,000 metric tons and higher lithium prices. Revenue rose 137% to $2.468 billion, surpassing analyst estimates...
Kuehn Law, PLLC is investigating whether certain officers and directors of Arcus Biosciences, Inc. breached their fiduciary duties through potential self-dealing. The investigation could lead to shareholder damages and corporate governance reforms. L...
Kuehn Law, PLLC is investigating whether certain officers and directors of EXELIXIS, Inc. breached their fiduciary duties through potential self-dealing. This probe could lead to shareholder damages and demands for corporate governance reforms. Long-...
